AcelRx Pharmaceuticals's Earnings: A Preview


AcelRx Pharmaceuticals ACRX is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement.

Analysts estimate that AcelRx Pharmaceuticals will likely report an Earnings Per Share (EPS) of $-0.07

AcelRx Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed on EPS by 0.00%, which was followed by a 16.57% drop in the share price the next day.

Here's a look at AcelRx Pharmaceuticals's past performance and the resulting price change:

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate -0.08 -0.08 -0.1 -0.08
EPS Actual -0.08 -0.08 -0.1 -0.10
Price Change % -16.57% 9.32% -14.68% -22.46%

Stock Performance

Shares of AcelRx Pharmaceuticals were trading at $0.7966 as of November 11. Over the last 52-week period, shares are down 45.7%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all upcoming earnings announcements, click here to use Benzinga Earnings Calendar.

Market News and Data brought to you by Benzinga APIs
Posted In: EarningsBZI-EP
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!